Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019964
Filing Date
2021-08-16
Accepted
2021-08-16 07:31:08
Documents
51
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20210630_10q.htm   iXBRL 10-Q 815053
2 EXHIBIT 3.1 ex_266174.htm EX-3.1 214892
3 EXHIBIT 31.1 ex_254490.htm EX-31.1 13855
4 EXHIBIT 31.2 ex_266042.htm EX-31.2 13858
5 EXHIBIT 32.1 ex_254491.htm EX-32.1 8633
  Complete submission text file 0001437749-21-019964.txt   4111014

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cbli-20210630.xsd EX-101.SCH 39808
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20210630_cal.xml EX-101.CAL 24750
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20210630_def.xml EX-101.DEF 249650
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20210630_lab.xml EX-101.LAB 249128
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20210630_pre.xml EX-101.PRE 271865
11 EXTRACTED XBRL INSTANCE DOCUMENT cbli20210630_10q_htm.xml XML 503355
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Cytocom, Inc. (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 211174529
SIC: 2834 Pharmaceutical Preparations